Company and Stock Identity

How Biofourmis Connects to the Public Market

Company structure
Private business following the CopilotIQ merger
Market access
No direct public shares are available.
Research focus
Separate the current care-at-home business from the life-sciences operation sold to ActiGraph. Follow monitoring alerts through clinical response and patient care.

Biofourmis announced a merger with CopilotIQ. Its former life-sciences business was acquired by ActiGraph in January 2025, so older descriptions can mix businesses that are now separate.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

No dated update is in the editorial file yet. Use the verified company sources below and check the profile verification date before relying on an older announcement.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: Remote-care teams work alongside data scientists and engineers. Clinical implementation connects monitoring with the staff responsible for follow-up.

Qualification signal: Clinical operations and remote-care workflow experience is valuable beside technical skill. Regulated device, nursing, or clinical credentials apply to the roles that own those responsibilities.

Check current roles at Biofourmis. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Virtual care, population health, nursing, service-line leadership, care management, and payer teams
Primary use case
Monitor patients outside the facility and route clinically meaningful changes to a care team
Typical deployment
Usually combines connected devices, patient applications, analytics, EHR integration, and either vendor or health-system clinical staffing

Evidence questions

  • Which outcomes improved for the target condition and patient population?
  • What are adherence, dropout, false alert, and escalation rates?
  • Does the evidence include the same staffing model being proposed to us?

Regulatory and workflow questions

  • Which device and software components require authorization for their stated use?
  • Who holds clinical responsibility for alerts at every hour?
  • What happens when readings are missing, implausible, delayed, or ignored?

Data and contract questions

  • Which device, symptom, location, and patient-reported data are collected?
  • How are identity, consent, device security, and home connectivity handled?
  • Can alert history, interventions, and outcomes be exported for independent review?

Evidence and Regulation

FDA Clearances on Record

No clearance is linked in this directory. That is not automatically a mark against the company. Some products support the people doing the work instead of reading a patient image or signal themselves.

First-Hand Sources